Cargando…
High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignant tumors and early detection contributes to a better prognosis. Finding new biomarkers for the diagnosis or treatment remains meaningful. DEF6 guanine nucleotide exchange factor (DEF6) is upregulated in ccRCC compared...
Autores principales: | Zhu, Zhen-Peng, Lin, Lan-Ruo, Lv, Tong-De, Xu, Chun-Ru, Cai, Tian-Yu, Lin, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551049/ https://www.ncbi.nlm.nih.gov/pubmed/33000227 http://dx.doi.org/10.3892/or.2020.7736 |
Ejemplares similares
-
Increased DEF6 expression is correlated with metastasis and poor prognosis in human osteosarcoma
por: Zhang, Qiao, et al.
Publicado: (2020) -
DEF6 expression in ovarian carcinoma correlates with poor patient survival
por: Liew, Phui-Ly, et al.
Publicado: (2016) -
Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Liu, Xianhui, et al.
Publicado: (2022) -
Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma
por: Gao, Yuan, et al.
Publicado: (2020) -
Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma
por: Su, Hengchuan, et al.
Publicado: (2016)